SCHEMBL30268487

SCHEMBL30268487

CCc1sc(NS(=O)(=O)c2cc(-c3cc(F)ccc3F)c(Cl)s2)nc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.42
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
FBP1 P09467 1/20 0.39
GRM4 Q14833 2/20 0.35
PTGER3 P43115 4/20 0.35
HSD17B10 Q99714 1/20 0.35
FSCN1 Q16658 1/20 0.35
SCN9A Q15858 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CG P48736 1/20 0.34
PIK3C3 Q8NEB9 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL793764 0.83 ALDH1A1 (0.45) ALDH1A1LMNATP53HTT
SCHEMBL793558 0.83 ALDH1A1 (0.62) ALDH1A1LMNAHTT
SCHEMBL30268167 0.81 PYGL (0.41) ALDH1A1LMNASCN9AHTT
SCHEMBL30268509 0.79 SCN9A (0.40) PTGER3SCN9A
SCHEMBL793187 0.79 PFKFB3 (0.39) ALDH1A1LMNAGRM4PTGER3FSCN1
SCHEMBL787588 0.70 SLC9A1 (0.36) LMNASCN9ACA12CA1CA2
SCHEMBL30268211 0.67 NPSR1 (0.58) HSD11B1
SCHEMBL15055847 0.67 PFKFB3 (0.51) ALDH1A1HSD17B10TP53
SCHEMBL9997036 0.67 PFKFB3 (0.59) ALDH1A1HSD17B10
SCHEMBL5911632 0.66 HTT (0.54) HSD11B1HSD17B10FSCN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047816-A1 PFKFB3 INHIBITORS AND THEIR USES GERO PTE. LTD. (SG) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047816-A1 PFKFB3 INHIBITORS AND THEIR USES PFKFB3, PFKFB4, PFKFB1 HSD11B1 3326/4885ALDH1A1 1943/4885LMNA 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.